Curative effect of Ranibizumab combined with laser photocoagulation for proliferative diabetic retinopathy
Journal Title: Guoji Yanke Zazhi - Year 2018, Vol 18, Issue 4
Abstract
AIM:To investigate the clinical efficacy of Ranibizumab combined with laser photocoagulation in the treatment of proliferative diabetic retinopathy(PDR). <p>METHODS: Totally 80 patients(101 eyes)with PDR admitted to our hospital from October 2014 and October 2016 were selected and divided into the observation group and the control group, with 50 eyes and 51 eyes respectively. The patients in the control group(50 eyes)were treated with panretinal photocoagulation(PRP), and the patients in observation group(51 eyes)were treated with ranibizumab on the basis of PRP treatment. Best corrected visual acuity(BCVA)was compared before and after surgery 1, 3, and 6mo. Optical coherence tomography(OCT)was used to examine the central macular thickness(CMT)and the area of neovascularization at each timepoints. Then the laser spot number, laser energy and energy density were compared between the two groups and the adverse reactions were recorded. <p>RESULTS: Postoperative BCVA of the two groups significantly increased, and the BCVA of observation group were significantly higher than that of the control group after surgery 1, 3, 6mo, the difference was statistically significant(<i>P</i><0.05). After treatment, the CMT and neovascularization area of the two groups significantly decreased, and those of the observation group were significantly lower than those of the control group after surgery 1, 3, 6mo, the difference was statistically significant(<i>P</i><0.05). The laser spot number, laser energy and energy density of the observation group were significantly lower than those of the control group, the difference was statistically significant(<i>P</i><0.05). There were 2 cases(2 eyes)in the observation group and 1 cases(1 eye)in the control group, whose intraocular pressure exceeded 28mmHg, while relieved rapidly after the treatment, and no obvious complications occurred in two groups. <p>CONCLUSION: Ranibizumab combined with laser in the treatment of PDR is an effective and safe way to improve BCVA, reduce CMT, and eliminate new blood vessels with less required laser energy.
Authors and Affiliations
Fan-Yi Meng
Keywords
Related Articles
- EP ID EP656095
- DOI 10.3980/j.issn.1672-5123.2018.4.10
- Views 120
- Downloads 0
Orthokeratology lens and conventional frame glasses for ocular parameters of myopia adolescent
AIM: To explore the effects of overnight orthokeratology lens and conventional frame glasses on the myopic diopter, uncorrected visual acuity and ocular parameters of myopia adolescent. <p>METHODS: Totally 102 cases of(2...
Intravitreal Ranibizumab injection combined with trabeculectomy and PRP for neovascular glaucoma
AIM: To determine the medium term efficacy of intravitreal ranibizumab injection combined with subsequent trabeculectomy and panretinal photocoagulation(PRP)for the treatment of neovascular glaucoma(NVG). <p>METHODS: In...
Clinical significance of reopening anterior chamber angle for severe acute angle-closure glaucoma
AIM: To explore whether the drainage angle could be reopened by surgery in patients with severe acute angle-closure glaucoma at “the greatest degree” of angle closure, and to study the treatment methods, such as double-p...
Clinical efficacy of disinhibition and visual function training in children patients with anisometropic amblyopia
AIM:To evaluate the clinical efficacy of treatment <i>via</i> disinhibition and visual function training in children patients with anisometropic amblyopia. <p>METHODS: Eighty-three children patients with anisometropic am...
XEN gel stent drainage device implantation for glaucoma
Glaucoma is one of the main causes of blindness in China. The higher the intraocular pressure, the severer the optic nerve injury. Lowering the intraocular pressure is the main treatment of delaying the progression in gl...